BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 32980391)

  • 1. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma.
    Yan J; Wang ZH; Yan Y; Luo HN; Ren XY; Li N; Zheng GX; Hou J
    Oncol Rep; 2020 Nov; 44(5):2080-2092. PubMed ID: 33000261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu).
    Gao X; Fan X; Zeng W; Liang J; Guo N; Yang X; Zhao Y
    Bioengineered; 2022 Mar; 13(3):7881-7893. PubMed ID: 35294329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
    Chen L; Yao H; Wang K; Liu X
    J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA HOXA11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma.
    Xu J; Bo Q; Zhang X; Lei D; Wang J; Pan X
    Oncol Res; 2020 May; 28(3):311-319. PubMed ID: 31987067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.
    Li MM; Dong CX; Sun B; Lei HZ; Wang YL; Gong YB; Sun LL; Sun ZW
    Life Sci; 2019 Dec; 239():116946. PubMed ID: 31610202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the Therapeutic Potential of LncRNA
    Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
    Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
    Gao Z; Li S; Zhou X; Li H; He S
    Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells.
    Li J; Momen-Heravi F; Wu X; He K
    Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
    Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway.
    Cheng H; Wang W; Wang G; Wang A; Du L; Lou W
    Med Sci Monit; 2018 Feb; 24():768-781. PubMed ID: 29410394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking long noncoding RNA MALAT1 restrained the development of laryngeal and hypopharyngeal carcinoma.
    Xu E; Liang X; Ji Z; Zhao S; Li L; Lang J
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):611-621. PubMed ID: 31792655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma.
    Zhao Y; Wang N; Zhang X; Liu H; Yang S
    J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNA X-Inactive Specific Transcript Promotes Esophageal Squamous Cell Carcinoma Progression via the MicroRNA 34a/Zinc Finger E-box-Binding Homeobox 1 Pathway.
    Guo B; He M; Ma M; Tian Z; Jin J; Tian G
    Dig Dis Sci; 2024 Apr; 69(4):1169-1181. PubMed ID: 38366093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma.
    Yu L; Shao X; Huo L; Zhang T
    Med Sci Monit; 2020 Sep; 26():e924187. PubMed ID: 32879299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
    Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
    World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.